Stefano Gelibter

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Journal: CNS drugs

Published: September 28, 2025

Changes in circulating pro-inflammatory lymphocytes and cortical excitability with extended-interval natalizumab dosing in multiple sclerosis.

Changes in circulating pro-inflammatory lymphocytes and cortical excitability with extended-interval natalizumab dosing in multiple sclerosis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 31, 2025

Combination therapy with cyclophosphamide, rituximab and corticosteroids in order to arrest a rapidly progressive primary CNS vasculitis: a case report with 40-month follow-up remission.

Combination therapy with cyclophosphamide, rituximab and corticosteroids in order to arrest a rapidly progressive primary CNS vasculitis: a case report with 40-month follow-up remission.

Journal: Clinical neurology and neurosurgery

Published: November 14, 2024

Do immune checkpoint inhibitors affect the course of multiple sclerosis? A systematic review and meta-analysis.

Do immune checkpoint inhibitors affect the course of multiple sclerosis? A systematic review and meta-analysis.

Journal: European journal of neurology

Published: July 04, 2024

Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis.

Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: February 02, 2024

As time goes by: Treatment challenges in elderly people with multiple sclerosis.

As time goes by: Treatment challenges in elderly people with multiple sclerosis.

Journal: Journal of neuroimmunology

Published: December 20, 2023

Tixagevimab and cilgavimab use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder during anti-CD20 treatment: A single-center experience.

Tixagevimab and cilgavimab use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder during anti-CD20 treatment: A single-center experience.

Journal: Journal of neuroimmunology

Published: June 12, 2023

Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19.

Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19.

Journal: Journal of neurology

Published: September 07, 2021

The impact of storage on extracellular vesicles: A systematic study.

The impact of storage on extracellular vesicles: A systematic study.

Journal: Journal of extracellular vesicles

Published: April 18, 2021

Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?

Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?

Journal: Journal of neurology

Published: March 03, 2021

Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis.

Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis.

Journal: Annals of neurology

Published: January 20, 2021

COVID-19 with no antibody response in a multiple sclerosis patient treated with cladribine: Implication for vaccination program?

COVID-19 with no antibody response in a multiple sclerosis patient treated with cladribine: Implication for vaccination program?

Journal: Multiple sclerosis and related disorders

Published: January 07, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026